Janus Henderson Group PLC Alnylam Pharmaceuticals, Inc. Transaction History

Janus Henderson Group PLC

$182 Billion
Q2 2024

A detailed history of Janus Henderson Group PLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 249,440 shares of ALNY stock, worth $66 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

249,440

Previous 178,954 39.39%

Holding current value

$66 Million

Previous $26.7 Million 126.64%

% of portfolio

0.03%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$143.31 - $247.0 $10.1 Million - $17.4 Million	70,486 Added 39.39%	249,440 $60.6 Million
Q1 2024 May 15, 2024	SELL	$146.51 - $198.2 $14.5 Million - $19.6 Million	-99,127 Reduced 35.65%	178,954 $26.7 Million
Q4 2023 Feb 14, 2024	SELL	$151.41 - $196.57 $2.33 Million - $3.03 Million	-15,409 Reduced 5.25%	278,081 $53.2 Million
Q3 2023 Nov 14, 2023	BUY	$170.77 - $211.65 $281,941 - $349,434	1,651 Added 0.57%	293,490 $52 Million
Q2 2023 Aug 14, 2023	SELL	$185.01 - $212.05 $1.3 Million - $1.49 Million	-7,004 Reduced 2.34%	291,839 $55.4 Million
Q1 2023 May 15, 2023	SELL	$182.66 - $235.53 $30.4 Million - $39.2 Million	-166,545 Reduced 35.79%	298,843 $59.9 Million
Q4 2022 Feb 14, 2023	SELL	$185.53 - $241.31 $20.2 Million - $26.3 Million	-109,116 Reduced 18.99%	465,388 $111 Million
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $17.3 Million - $29 Million	124,791 Added 27.75%	574,504 $115 Million
Q2 2022 Aug 15, 2022	SELL	$120.42 - $169.29 $17.9 Million - $25.2 Million	-148,735 Reduced 24.85%	449,713 $65.6 Million
Q1 2022 May 16, 2022	BUY	$127.18 - $173.91 $12.4 Million - $16.9 Million	97,115 Added 19.37%	598,448 $97.7 Million
Q4 2021 Feb 14, 2022	BUY	$159.56 - $209.29 $76.5 Million - $100 Million	479,756 Added 2223.46%	501,333 $85 Million
Q3 2021 Nov 16, 2021	BUY	$169.75 - $207.73 $1.67 Million - $2.05 Million	9,852 Added 84.03%	21,577 $4.08 Million
Q2 2021 Aug 16, 2021	SELL	$128.63 - $176.89 $830,692 - $1.14 Million	-6,458 Reduced 35.52%	11,725 $1.99 Million
Q1 2021 May 17, 2021	SELL	$126.83 - $175.69 $9.14 Million - $12.7 Million	-72,072 Reduced 79.85%	18,183 $2.57 Million
Q4 2020 Feb 16, 2021	SELL	$122.97 - $147.0 $8.89 Million - $10.6 Million	-72,314 Reduced 44.48%	90,255 $11.7 Million
Q3 2020 Nov 16, 2020	SELL	$121.19 - $165.49 $7.4 Million - $10.1 Million	-61,092 Reduced 27.31%	162,569 $23.7 Million
Q2 2020 Aug 14, 2020	SELL	$104.21 - $156.44 $19.2 Million - $28.8 Million	-183,796 Reduced 45.11%	223,661 $33.1 Million
Q1 2020 May 14, 2020	BUY	$93.12 - $133.99 $33 Million - $47.4 Million	353,980 Added 661.93%	407,457 $44.4 Million
Q4 2019 Feb 18, 2020	BUY	$74.51 - $124.23 $964,010 - $1.61 Million	12,938 Added 31.91%	53,477 $6.16 Million
Q3 2019 Nov 14, 2019	BUY	$70.9 - $87.82 $977,569 - $1.21 Million	13,788 Added 51.54%	40,539 $3.26 Million
Q2 2019 Jul 31, 2019	BUY	$65.86 - $92.79 $99,316 - $139,927	1,508 Added 5.97%	26,751 $1.94 Million
Q1 2019 Apr 30, 2019	BUY	$72.76 - $93.45 $61,191 - $78,591	841 Added 3.45%	25,243 $2.36 Million
Q4 2018 Feb 06, 2019	SELL	$62.67 - $88.33 $75,204 - $105,996	-1,200 Reduced 4.69%	24,402 $1.78 Million
Q3 2018 Nov 09, 2018	SELL	$87.52 - $122.67 $6.73 Million - $9.43 Million	-76,900 Reduced 75.02%	25,602 $2.24 Million
Q2 2018 Aug 10, 2018	SELL	$88.31 - $107.8 $35.5 Million - $43.3 Million	-401,809 Reduced 79.67%	102,502 $10.1 Million
Q1 2018 May 14, 2018	BUY	$115.92 - $148.54 $1.24 Million - $1.59 Million	10,692 Added 2.17%	504,311 $60.1 Million
Q4 2017 Feb 09, 2018	SELL	$114.49 - $139.98 $21.7 Million - $26.5 Million	-189,401 Reduced 27.73%	493,619 $62.7 Million
Q3 2017 Nov 14, 2017	BUY	$72.53 - $118.27 $1.14 Million - $1.86 Million	15,687 Added 2.35%	683,020 $0
Q2 2017 Aug 17, 2017	BUY	N/A	667,333	667,333 $53.2 Million

Others Institutions Holding ALNY

# of Institutions

654

Shares Held

111M

Call Options Held

2.14M

Put Options Held

1.91M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $32.6B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Alnylam Pharmaceuticals, Inc. Transaction History